SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 20.77 |
| Enterprise Value ($M) | 18.13 |
| Book Value ($M) | -1.87 |
| Book Value / Share | -0.11 |
| Price / Book | -11.08 |
| NCAV ($M) | -2.13 |
| NCAV / Share | -0.12 |
| Price / NCAV | -9.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -2.11 |
| Return on Equity (ROE) | -3.90 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.84 |
| Current Ratio | 0.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.92 |
| Assets | 3.18 |
| Liabilities | 5.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -13.30 |
| Net Income | -11.28 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -8.45 |
| Cash from Investing | 3.65 |
| Cash from Financing | 3.90 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Gordon Ariel | 6.90 | 0.73 | |
| 13G/A | Ben-Noon Alon | 19.98 | 1.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,956 | 61,157 | 27.73 | |
| 8,649 | 5,695 | 151.87 | |
| 6,248 | 63,059 | 9.91 | |
| 7,756 | 96,731 | 8.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NKTR – Nektar Therapeutics | NLSP – NLS Pharmaceutics Ltd. |
| NRBO – NeuroBo Pharmaceuticals, Inc. | NRXP – NRx Pharmaceuticals, Inc. |
| NTBL – Notable Labs, Ltd. |
Financial data and stock pages provided by
Fintel.io